Standard

Stress echo 2030 : The novel ABCDE-(FGLPR) protocol to define the future of imaging. / Stress Echo 2030 Study Group of the Italian Society of Echocardiography Cardiovascular Imaging.

в: Journal of Clinical Medicine, Том 10, № 16, 3641, 17.08.2021.

Результаты исследований: Научные публикации в периодических изданияхстатьяРецензирование

Harvard

Stress Echo 2030 Study Group of the Italian Society of Echocardiography Cardiovascular Imaging 2021, 'Stress echo 2030: The novel ABCDE-(FGLPR) protocol to define the future of imaging', Journal of Clinical Medicine, Том. 10, № 16, 3641. https://doi.org/10.3390/jcm10163641

APA

Stress Echo 2030 Study Group of the Italian Society of Echocardiography Cardiovascular Imaging (2021). Stress echo 2030: The novel ABCDE-(FGLPR) protocol to define the future of imaging. Journal of Clinical Medicine, 10(16), [3641]. https://doi.org/10.3390/jcm10163641

Vancouver

Stress Echo 2030 Study Group of the Italian Society of Echocardiography Cardiovascular Imaging. Stress echo 2030: The novel ABCDE-(FGLPR) protocol to define the future of imaging. Journal of Clinical Medicine. 2021 Авг. 17;10(16). 3641. https://doi.org/10.3390/jcm10163641

Author

Stress Echo 2030 Study Group of the Italian Society of Echocardiography Cardiovascular Imaging. / Stress echo 2030 : The novel ABCDE-(FGLPR) protocol to define the future of imaging. в: Journal of Clinical Medicine. 2021 ; Том 10, № 16.

BibTeX

@article{1c6c1bc0b8c94848a9beba234dc36e0d,
title = "Stress echo 2030: The novel ABCDE-(FGLPR) protocol to define the future of imaging",
abstract = "With stress echo (SE) 2020 study, a new standard of practice in stress imaging was developed and disseminated: The ABCDE protocol for functional testing within and beyond CAD. ABCDE protocol was the fruit of SE 2020, and is the seed of SE 2030, which is articulated in 12 projects: 1-SE in coronary artery disease (SECAD); 2-SE in diastolic heart failure (SEDIA); 3-SE in hypertrophic cardiomyopathy (SEHCA); 4-SE post-chest radiotherapy and chemotherapy (SERA); 5-Artificial intelligence SE evaluation (AI-SEE); 6-Environmental stress echocardiography and air pollution (ESTER); 7-SE in repaired Tetralogy of Fallot (SETOF); 8-SE in post-COVID-19 (SECOV); 9: Recovery by stress echo of conventionally unfit donor good hearts (RESURGE); 10-SE for mitral ischemic regurgitation (SEMIR); 11-SE in valvular heart disease (SEVA); 12-SE for coronary vasospasm (SESPASM). The study aims to recruit in the next 5 years (2021-2025)≥10,000 patients followed for≥5 years (up to 2030) from≥20 quality-controlled laboratories from≥10 countries. In this COVID-19 era of sustainable health care delivery, SE2030 will provide the evidence to finally recommend SE as the optimal and versatile imaging modality for functional testing anywhere, any time, and in any patient.",
keywords = "Effectiveness, Registry, Stress echocardiography, Sustainability, effectiveness, registry, PRESERVED EJECTION FRACTION, GRADIENT AORTIC-STENOSIS, HEART-RATE RESERVE, sustainability, EUROPEAN ASSOCIATION, PROGNOSTIC VALUE, HYPERTROPHIC CARDIOMYOPATHY, FLOW RESERVE, stress echocardiography, DESCENDING CORONARY-ARTERY, EXPERT CONSENSUS, AMERICAN SOCIETY",
author = "{Stress Echo 2030 Study Group of the Italian Society of Echocardiography Cardiovascular Imaging} and Eugenio Picano and Quirino Ciampi and Lauro Cortigiani and Arruda-Olson, {Adelaide M.} and Clarissa Borguezan-Daros and Pretto, {Jos{\'e} Luis De Castro E.Silva} and Rosangela Cocchia and Eduardo Bossone and Elisa Merli and Kane, {Garvan C.} and Albert Varga and Gergely Agoston and Scali, {Maria Chiara} and Doralisa Morrone and Iana Simova and Martina Samardjieva and Alla Boshchenko and Tamara Ryabova and Alexander Vrublevsky and Attila Palinkas and Palinkas, {Eszter D.} and Robert Sepp and Torres, {Marco A.R.} and Villarraga, {Hector R.} and Preradovi{\'c}, {Tamara Kova{\v c}evi{\'c}} and Rodolfo Citro and Miguel Amor and Hugo Mosto and Michael Salam{\`e} and Paul Leeson and Cristina Mangia and Nicola Gaibazzi and Domenico Tuttolomondo and Costantina Prota and Jesus Peteiro and {Van De Heyning}, {Caroline M.} and Antonello D'Andrea and Fausto Rigo and Aleksandra Nikolic and Miodrag Ostojic and Jorge Lowenstein and Rosina Arbucci and {Lowenstein Haber}, {Diego M.} and Merlo, {Pablo M.} and Karina Wierzbowska-Drabik and Kasprzak, {Jaroslaw D.} and Maciej Haberka and Camarozano, {Ana Cristina} and Nithima Ratanasit and Angela Zagatina",
note = "Publisher Copyright: {\textcopyright} 2021 by the authors. Licensee MDPI, Basel, Switzerland.",
year = "2021",
month = aug,
day = "17",
doi = "10.3390/jcm10163641",
language = "English",
volume = "10",
journal = "Journal of Clinical Medicine",
issn = "2077-0383",
publisher = "MDPI AG",
number = "16",

}

RIS

TY - JOUR

T1 - Stress echo 2030

T2 - The novel ABCDE-(FGLPR) protocol to define the future of imaging

AU - Stress Echo 2030 Study Group of the Italian Society of Echocardiography Cardiovascular Imaging

AU - Picano, Eugenio

AU - Ciampi, Quirino

AU - Cortigiani, Lauro

AU - Arruda-Olson, Adelaide M.

AU - Borguezan-Daros, Clarissa

AU - Pretto, José Luis De Castro E.Silva

AU - Cocchia, Rosangela

AU - Bossone, Eduardo

AU - Merli, Elisa

AU - Kane, Garvan C.

AU - Varga, Albert

AU - Agoston, Gergely

AU - Scali, Maria Chiara

AU - Morrone, Doralisa

AU - Simova, Iana

AU - Samardjieva, Martina

AU - Boshchenko, Alla

AU - Ryabova, Tamara

AU - Vrublevsky, Alexander

AU - Palinkas, Attila

AU - Palinkas, Eszter D.

AU - Sepp, Robert

AU - Torres, Marco A.R.

AU - Villarraga, Hector R.

AU - Preradović, Tamara Kovačević

AU - Citro, Rodolfo

AU - Amor, Miguel

AU - Mosto, Hugo

AU - Salamè, Michael

AU - Leeson, Paul

AU - Mangia, Cristina

AU - Gaibazzi, Nicola

AU - Tuttolomondo, Domenico

AU - Prota, Costantina

AU - Peteiro, Jesus

AU - Van De Heyning, Caroline M.

AU - D'Andrea, Antonello

AU - Rigo, Fausto

AU - Nikolic, Aleksandra

AU - Ostojic, Miodrag

AU - Lowenstein, Jorge

AU - Arbucci, Rosina

AU - Lowenstein Haber, Diego M.

AU - Merlo, Pablo M.

AU - Wierzbowska-Drabik, Karina

AU - Kasprzak, Jaroslaw D.

AU - Haberka, Maciej

AU - Camarozano, Ana Cristina

AU - Ratanasit, Nithima

AU - Zagatina, Angela

N1 - Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.

PY - 2021/8/17

Y1 - 2021/8/17

N2 - With stress echo (SE) 2020 study, a new standard of practice in stress imaging was developed and disseminated: The ABCDE protocol for functional testing within and beyond CAD. ABCDE protocol was the fruit of SE 2020, and is the seed of SE 2030, which is articulated in 12 projects: 1-SE in coronary artery disease (SECAD); 2-SE in diastolic heart failure (SEDIA); 3-SE in hypertrophic cardiomyopathy (SEHCA); 4-SE post-chest radiotherapy and chemotherapy (SERA); 5-Artificial intelligence SE evaluation (AI-SEE); 6-Environmental stress echocardiography and air pollution (ESTER); 7-SE in repaired Tetralogy of Fallot (SETOF); 8-SE in post-COVID-19 (SECOV); 9: Recovery by stress echo of conventionally unfit donor good hearts (RESURGE); 10-SE for mitral ischemic regurgitation (SEMIR); 11-SE in valvular heart disease (SEVA); 12-SE for coronary vasospasm (SESPASM). The study aims to recruit in the next 5 years (2021-2025)≥10,000 patients followed for≥5 years (up to 2030) from≥20 quality-controlled laboratories from≥10 countries. In this COVID-19 era of sustainable health care delivery, SE2030 will provide the evidence to finally recommend SE as the optimal and versatile imaging modality for functional testing anywhere, any time, and in any patient.

AB - With stress echo (SE) 2020 study, a new standard of practice in stress imaging was developed and disseminated: The ABCDE protocol for functional testing within and beyond CAD. ABCDE protocol was the fruit of SE 2020, and is the seed of SE 2030, which is articulated in 12 projects: 1-SE in coronary artery disease (SECAD); 2-SE in diastolic heart failure (SEDIA); 3-SE in hypertrophic cardiomyopathy (SEHCA); 4-SE post-chest radiotherapy and chemotherapy (SERA); 5-Artificial intelligence SE evaluation (AI-SEE); 6-Environmental stress echocardiography and air pollution (ESTER); 7-SE in repaired Tetralogy of Fallot (SETOF); 8-SE in post-COVID-19 (SECOV); 9: Recovery by stress echo of conventionally unfit donor good hearts (RESURGE); 10-SE for mitral ischemic regurgitation (SEMIR); 11-SE in valvular heart disease (SEVA); 12-SE for coronary vasospasm (SESPASM). The study aims to recruit in the next 5 years (2021-2025)≥10,000 patients followed for≥5 years (up to 2030) from≥20 quality-controlled laboratories from≥10 countries. In this COVID-19 era of sustainable health care delivery, SE2030 will provide the evidence to finally recommend SE as the optimal and versatile imaging modality for functional testing anywhere, any time, and in any patient.

KW - Effectiveness

KW - Registry

KW - Stress echocardiography

KW - Sustainability

KW - effectiveness

KW - registry

KW - PRESERVED EJECTION FRACTION

KW - GRADIENT AORTIC-STENOSIS

KW - HEART-RATE RESERVE

KW - sustainability

KW - EUROPEAN ASSOCIATION

KW - PROGNOSTIC VALUE

KW - HYPERTROPHIC CARDIOMYOPATHY

KW - FLOW RESERVE

KW - stress echocardiography

KW - DESCENDING CORONARY-ARTERY

KW - EXPERT CONSENSUS

KW - AMERICAN SOCIETY

UR - http://www.scopus.com/inward/record.url?scp=85113778069&partnerID=8YFLogxK

U2 - 10.3390/jcm10163641

DO - 10.3390/jcm10163641

M3 - Article

AN - SCOPUS:85113778069

VL - 10

JO - Journal of Clinical Medicine

JF - Journal of Clinical Medicine

SN - 2077-0383

IS - 16

M1 - 3641

ER -

ID: 85561058